# Author Interview Series SNO Podcast May 2026

Page: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026
Text version: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026.md
Podcast: [Neuro-Oncology: The Podcast](https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653)
Published: 2026-05-25T10:00:00+00:00
Episode link: https://soc-neuro-onc.libsyn.com/author-interview-series-sno-podcast-may-2026
Audio file: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-138B.mp3?dest-id=2339594
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-series-sno-podcast-may-2026
Duration seconds: 983

## Resource

Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-series-sno-podcast-may-2026/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-series-sno-podcast-may-2026.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.